Active immuno-oncological agents in development worldwide by type 2017 vs. 2019
In 2019, there were 1,202 cell therapy drugs active in various stages of clinical trials, compared to just over 400 in development in 2017. This statistic shows the active immuno-oncological agents in the global drug development pipeline in 2017 and 2019, by therapy type.